Reassessment of the Risk of Hemolytic Syndrome in Patients With Chronic Lymphocytic Leukemia Treated With a Regimen Containing Venetoclax

NCT07691047 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Chronic Lymphoid Leukemia

Interventions

PROCEDURE: Cervical, Thoracic, Abdominal, and Pelvic CT Scan

Sponsor

Private Hospital of Confluent, France